Jeffrey A. Engler - Publications

Affiliations: 
University of Alabama, Birmingham, Birmingham, AL, United States 
Area:
Biochemistry, Molecular Biology

39 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2007 Engler JA, Hong JS. Characterization of the adenovirus fiber protein. Methods in Molecular Medicine. 131: 281-98. PMID 17656791 DOI: 10.1007/978-1-59745-277-9_21  0.328
2007 Ehrhardt A, Yant SR, Giering JC, Xu H, Engler JA, Kay MA. Somatic integration from an adenoviral hybrid vector into a hot spot in mouse liver results in persistent transgene expression levels in vivo. Molecular Therapy : the Journal of the American Society of Gene Therapy. 15: 146-56. PMID 17164786 DOI: 10.1038/Sj.Mt.6300011  0.336
2006 Ehrhardt A, Engler JA, Xu H, Cherry AM, Kay MA. Molecular analysis of chromosomal rearrangements in mammalian cells after phiC31-mediated integration. Human Gene Therapy. 17: 1077-94. PMID 17069535 DOI: 10.1089/Hum.2006.17.1077  0.324
2006 Ehrhardt A, Engler JA, Xu H, Cherry A, Kay MA. 388. Chromosomal Rearrangements in Mammalian Cells Are Induced at High Frequency by the Bacteriophage Derived Integrase phiC31 Molecular Therapy. 13: S148. DOI: 10.1016/J.Ymthe.2006.08.449  0.32
2005 Brouillette CG, Dong WJ, Yang ZW, Ray MJ, Protasevich II, Cheung HC, Engler JA. Förster resonance energy transfer measurements are consistent with a helical bundle model for lipid-free apolipoprotein A-I. Biochemistry. 44: 16413-25. PMID 16342934 DOI: 10.1021/Bi051018V  0.333
2005 Ehrhardt A, Xu H, Huang Z, Engler JA, Kay MA. A direct comparison of two nonviral gene therapy vectors for somatic integration: in vivo evaluation of the bacteriophage integrase phiC31 and the Sleeping Beauty transposase. Molecular Therapy : the Journal of the American Society of Gene Therapy. 11: 695-706. PMID 15851008 DOI: 10.1016/J.Ymthe.2005.01.010  0.342
2005 Ehrhardt A, Xu H, Yant SR, Engler JA, Kay MA. 600. A Novel Gene-Deleted Adenoviral Vector for Somatic Integration and Long-Term Phenotypic Correction of Murine and Canine Hemophilia B Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.07.140  0.335
2004 Pritchard DG, Dong S, Baker JR, Engler JA. The bifunctional peptidoglycan lysin of Streptococcus agalactiae bacteriophage B30. Microbiology (Reading, England). 150: 2079-87. PMID 15256551 DOI: 10.1099/Mic.0.27063-0  0.319
2004 Ehrhardt A, Engler JA, Calos MP, Kay MA. 811. The Hotspots of Integration Targeted by the Site-Specific Integrase PhiC31 May Be Cell Line Dependent Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.709  0.334
2000 Caterina JJ, Shi J, Kozak CA, Engler JA, Birkedal-Hansen H. Characterization, expression analysis and chromosomal mapping of mouse matrix metalloproteinase-19 (MMP-19). Molecular Biology Reports. 27: 73-9. PMID 11092553 DOI: 10.1023/A:1007196529604  0.333
2000 Caterina J, Shi J, Sun X, Qian Q, Yamada S, Liu Y, Krakora S, Bartlett JD, Yamada Y, Engler JA, Birkedal-Hansen H, Simmer JP. Cloning, characterization, and expression analysis of mouse enamelysin. Journal of Dental Research. 79: 1697-703. PMID 11023266 DOI: 10.1177/00220345000790091001  0.323
2000 Steele DL, El-Kabbani O, Dunten P, Windsor LJ, Kammlott RU, Crowther RL, Michoud C, Engler JA, Birktoft JJ. Expression, characterization and structure determination of an active site mutant (Glu202-Gln) of mini-stromelysin-1. Protein Engineering. 13: 397-405. PMID 10877850 DOI: 10.1093/Protein/13.6.397  0.358
2000 Caterina JJ, Yamada S, Caterina NC, Longenecker G, Holmbäck K, Shi J, Yermovsky AE, Engler JA, Birkedal-Hansen H. Inactivating mutation of the mouse tissue inhibitor of metalloproteinases-2(Timp-2) gene alters proMMP-2 activation. The Journal of Biological Chemistry. 275: 26416-22. PMID 10827176 DOI: 10.1074/Jbc.M001271200  0.33
1999 Caterina J, Shi J, Krakora S, Bartlett JD, Engler JA, Kozak CA, Birkedal-Hansen H. Isolation, characterization, and chromosomal location of the mouse enamelysin gene. Genomics. 62: 308-11. PMID 10610728 DOI: 10.1006/Geno.1999.5990  0.306
1999 Galazka G, Windsor LJ, Birkedal-Hansen H, Engler JA. Spontaneous propeptide processing of mini-stromelysin-1 mutants blocked by APMA ((4-Aminophenyl)mercuric acetate). Biochemistry. 38: 1316-22. PMID 9930993 DOI: 10.1021/Bi982135B  0.365
1999 Swindle CS, Zou N, Van Tine BA, Shaw GM, Engler JA, Chow LT. Human papillomavirus DNA replication compartments in a transient DNA replication system. Journal of Virology. 73: 1001-9. PMID 9882301 DOI: 10.1128/Jvi.73.2.1001-1009.1999  0.328
1998 Caterina NC, Windsor LJ, Bodden MK, Yermovsky AE, Taylor KB, Birkedal-Hansen H, Engler JA. Glycosylation and NH2-terminal domain mutants of the tissue inhibitor of metalloproteinases-1 (TIMP-1). Biochimica Et Biophysica Acta. 1388: 21-34. PMID 9774703 DOI: 10.1016/S0167-4838(98)00158-7  0.387
1998 Rogers DP, Roberts LM, Lebowitz J, Datta G, Anantharamaiah GM, Engler JA, Brouillette CG. The lipid-free structure of apolipoprotein A-I: effects of amino-terminal deletions. Biochemistry. 37: 11714-25. PMID 9718294 DOI: 10.1021/Bi973112K  0.334
1998 Sanchez V, Angeletti PC, Engler JA, Britt WJ. Localization of human cytomegalovirus structural proteins to the nuclear matrix of infected human fibroblasts Journal of Virology. 72: 3321-3329. PMID 9525659 DOI: 10.1128/Jvi.72.4.3321-3329.1998  0.329
1998 Angeletti PC, Engler JA. Adenovirus preterminal protein binds to the CAD enzyme at active sites of viral DNA replication on the nuclear matrix Journal of Virology. 72: 2896-2904. PMID 9525610 DOI: 10.1128/Jvi.72.4.2896-2904.1998  0.413
1998 Rogers DP, Roberts LM, Lebowitz J, Engler JA, Brouillette CG. Structural analysis of apolipoprotein A-I: effects of amino- and carboxy-terminal deletions on the lipid-free structure. Biochemistry. 37: 945-55. PMID 9454585 DOI: 10.1021/Bi9713512  0.342
1997 Dion LD, Goldsmith KT, Tang DC, Engler JA, Yoshida M, Garver RI. Amplification of recombinant adenoviral transgene products occurs by inhibition of histone deacetylase. Virology. 231: 201-9. PMID 9168882 DOI: 10.1006/Viro.1997.8538  0.353
1997 Rogers DP, Brouillette CG, Engler JA, Tendian SW, Roberts L, Mishra VK, Anantharamaiah GM, Lund-Katz S, Phillips MC, Ray MJ. Truncation of the amino terminus of human apolipoprotein A-I substantially alters only the lipid-free conformation. Biochemistry. 36: 288-300. PMID 9003180 DOI: 10.1021/Bi961876E  0.325
1996 Galazka G, Windsor LJ, Birkedal-Hansen H, Engler JA. APMA (4-aminophenylmercuric acetate) activation of stromelysin-1 involves protein interactions in addition to those with cysteine-75 in the propeptide Biochemistry. 35: 11221-11227. PMID 8780527 DOI: 10.1021/Bi960618E  0.344
1996 Angeletti PC, Engler JA. Tyrosine kinase-dependent release of an adenovirus preterminal protein complex from the nuclear matrix Journal of Virology. 70: 3060-3067. PMID 8627784 DOI: 10.1128/Jvi.70.5.3060-3067.1996  0.324
1994 Goldsmith KT, Curiel DT, Engler JA, Garver RI. Trans complementation of an E1A-deleted adenovirus with codelivered E1A sequences to make recombinant adenoviral producer cells Human Gene Therapy. 5: 1341-1348. PMID 7893805 DOI: 10.1089/Hum.1994.5.11-1341  0.343
1991 Shin Hong J, Engler JA. The amino terminus of the adenovirus fiber protein encodes the nuclear localization signal Virology. 185: 758-767. PMID 1962447 DOI: 10.1016/0042-6822(91)90547-O  0.342
1991 Joung I, Horwitz MS, Engler JA. Mutagenesis of conserved region I in the DNA polymerase from human adenovirus serotype 2 Virology. 184: 235-241. PMID 1871969 DOI: 10.1016/0042-6822(91)90840-8  0.399
1991 Fredman JN, Pettit SC, Horwitz MS, Engler JA. Linker insertion mutations in the adenovirus preterminal protein that affect DNA replication activity in vivo and in vitro Journal of Virology. 65: 4591-4597. PMID 1870189 DOI: 10.1128/Jvi.65.9.4591-4597.1991  0.37
1990 Mullis KG, Haltiwanger RS, Hart GW, Marchase RB, Engler JA. Relative accessibility of N-acetylglucosamine in trimers of the adenovirus types 2 and 5 fiber proteins Journal of Virology. 64: 5317-5323. PMID 2120471 DOI: 10.1128/Jvi.64.11.5317-5323.1990  0.305
1989 Pettit SC, Horwitz MS, Engler JA. Mutations of the precursor to the terminal protein of adenovirus serotypes 2 and 5 Journal of Virology. 63: 5244-5250. PMID 2511338 DOI: 10.1128/Jvi.63.12.5244-5250.1989  0.369
1988 Shu L, Pettit SC, Engler JA. The precise structure and coding capacity of mrnas from early region 2B of human adenovirus serotype 2 Virology. 165: 348-356. PMID 3407147 DOI: 10.1016/0042-6822(88)90579-X  0.363
1988 Pettit SC, Horwitz MS, Engler JA. Adenovirus preterminal protein synthesized in COS cells from cloned DNA is active in DNA replication in vitro Journal of Virology. 62: 496-500. PMID 3336069 DOI: 10.1128/Jvi.62.2.496-500.1988  0.37
1988 Hong JS, Mullis KG, Engler JA. Characterization of the early region 3 and fiber genes of Ad7 Virology. 167: 545-553. PMID 2849239 DOI: 10.1016/0042-6822(88)90117-1  0.322
1987 Shu L, Horwitz MS, Engler JA. Expression of enzymatically active adenovirus DNA POLYMERASE FROM CLONED DNA requires sequences upstream of the main open reading frame Virology. 161: 520-526. PMID 3686828 DOI: 10.1016/0042-6822(87)90146-2  0.379
1984 Kwoh TJ, Engler JA. The nucleotide sequence of the chicken thymidine kinase gene and the relationship of its predicted polypeptide to that of the vaccinia virus thymidine kinase Nucleic Acids Research. 12: 3959-3971. PMID 6328447 DOI: 10.1093/Nar/12.9.3959  0.317
1983 Engler JA, Hoppe MS, van Bree MP. The nucleotide sequence of the genes encoded in early region 2b of human adenovirus type 7. Gene. 21: 145-59. PMID 6301944 DOI: 10.1016/0378-1119(83)90156-7  0.363
1982 Stillman BW, Topp WC, Engler JA. Conserved sequences at the origin of adenovirus DNA replication. Journal of Virology. 44: 530-7. PMID 7143575 DOI: 10.1128/Jvi.44.2.530-537.1982  0.363
1977 Engler J, Inman RB. Site-specific recombination in bacteriophage lambda Journal of Molecular Biology. 113: 385-400. PMID 886614 DOI: 10.1016/0022-2836(77)90148-6  0.338
Show low-probability matches.